NCT06914336 Hepatic Doppler to Assess Venous Congestion During Invasive Mechanical Ventilation (DOHECOV)
| NCT ID | NCT06914336 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Brest |
| Condition | Congestion, Venous |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-03-24 |
| Primary Completion | 2028-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-03-24 with a primary completion date of 2028-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to investigate venous congestion using hepatic vein doppler for ICU patients with invasive mechanical ventilastion. The primary outcome is the systolic to diastolic hepatic vein velocity ratio S/D . The objective is to find a significant association between S/D and different congestion indicators.
Eligibility Criteria
Inclusion Criteria: * intubated for more than 24 hours Exclusion Criteria: * Chronic end-stage renal disease on admission * Atrial Fibrillation * Cirrhosis * Portal thrombosis * Refusal to participate * non-opposition could not be obtained from themselves or their trusted support person in the event of incapacity * Under legal protection.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06914336 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Congestion, Venous. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06914336 currently recruiting?
Yes, NCT06914336 is actively recruiting participants. Contact the research team at gwenael.prat@chu-brest.fr for enrollment information.
Where is the NCT06914336 trial being conducted?
This trial is being conducted at Brest, France.
Who is sponsoring the NCT06914336 clinical trial?
NCT06914336 is sponsored by University Hospital, Brest. The trial plans to enroll 100 participants.